Catalent, Inc. to Present at the Stephens Annual Investment Conference
23 November 2021 - 11:15PM
Business Wire
Catalent, Inc. (NYSE: CTLT), the global leader in enabling
pharma, biotech, and consumer health partners to optimize
development, launch, and supply of better patient treatments across
multiple modalities, today announced that members of its executive
leadership team will virtually present at the Stephens Annual
Investment Conference at 11:00 a.m. ET on November 29, 2021.
A live webcast of the presentation will be accessible at
http://investor.catalent.com and will be available for replay
following the event.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the
global leader in enabling pharma, biotech, and consumer health
partners to optimize product development, launch, and full
life-cycle supply for patients around the world. With broad and
deep scale and expertise in development sciences, delivery
technologies, and multi-modality manufacturing, Catalent is the
industry’s preferred partner for personalized medicines, consumer
health brand extensions, and blockbuster drugs. Catalent helps
accelerate over 1,000 partner programs and launch over 150 new
products every year. Its flexible manufacturing platforms at over
50 global sites supply over 70 billion doses of more than 7,000
products to over 1,000 customers annually. Catalent’s expert
workforce exceeds 17,000, including more than 2,500 scientists and
technicians. Headquartered in Somerset, New Jersey, the company
generated $4 billion in revenue in its 2021 fiscal year. For more
information, visit www.catalent.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20211123006036/en/
Investor Contact: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jul 2023 bis Jul 2024